Rheumatoid Arthritis
📧 Sign up to get email alerts when something new happens for Rheumatoid Arthritis.
Sign up freeTop drugs studied for this disease
-
EMA withdrawal · 2026-07-28EMA Withdrawn: Inflectra (infliximab) — Pfizer Europe MA EEIG
The EMA has withdrawn Inflectra (infliximab) from the market.
-
CLINICAL_TRIALS withdrawal · 2026-03-27Clinical Trial Update: Pregnancy and Medically Assisted Conception in Rare Diseases
Clinical trial NCT02450396 on pregnancy and medically assisted conception in rare autoimmune diseases has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2026-03-09Clinical Trial Update: Multidisciplinary Approach for Treat To Target In Rheumatoid Arthritis [NA]
This document notes that the clinical trial on a multidisciplinary, treat-to-target approach for rheumatoid arthritis has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2025-12-02Clinical Trial Update: Safety and Preliminary Signs of Efficacy of F8IL10 for Intra-articular Treatment [Phase 1]
A Phase 1 trial evaluating the intra-articular IL-10 fusion protein F8IL10 for rheumatoid arthritis was withdrawn.
-
CLINICAL_TRIALS withdrawal · 2025-10-06Clinical Trial Update: The Use of Synovial Biopsies in Predicting Response to Biologic Therapy in Rheumatoid Arthritis Patients [Phase 3]
Phase 3 clinical trial evaluating whether synovial biopsy findings can predict response to biologic therapy in rheumatoid arthritis, which h…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS withdrawal · 2025-09-25Clinical Trial Update: Pharmacokinetics and Pharmacodynamics of Biologic Drugs in Obese Patients With Arthritis [Phase 1]
A Phase 1 trial evaluating pharmacokinetics and pharmacodynamics of biologic drugs in obese patients with arthritis has been withdrawn, with…
-
CLINICAL_TRIALS withdrawal · 2025-08-17Clinical Trial Update: Identification of Genomic Biomarkers for Rheumatoid Arthritis With Late Onset
A clinical trial investigating genomic biomarkers for late-onset rheumatoid arthritis has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2025-07-14Clinical Trial Update: The GRK2 Inhibitor Paroxetine as a Novel Adjunct to Conventional Therapy in Rheumatoid Arthritis Patients [Phase 1, Phase 2]
A phase 1/2 clinical trial evaluating paroxetine as a GRK2 inhibitor adjunct to conventional therapy for rheumatoid arthritis has been withd…
-
CLINICAL_TRIALS withdrawal · 2025-06-05Clinical Trial Update: A Pilot Study to Explore the Role of Gut Flora in Rheumatoid Arthritis
ProgenaBiome's pilot trial examining the role of gut flora in rheumatoid arthritis has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2025-02-27Clinical Trial Update: ELECTOR Treat-to-target Via Home-based Disease Activity Monitoring of Patients With Rheumatoid Arthritis [NA]
The ELECTOR trial evaluating treat-to-target using home-based disease activity monitoring for rheumatoid arthritis was withdrawn.
-
CLINICAL_TRIALS withdrawal · 2024-12-24Clinical Trial Update: PMCF Study on the Safety, Performance and Clinical Benefits Data of the NexGen TM Augmentation Patella
The PMCF study evaluating the safety, performance and clinical benefits data of the NexGen TM Augmentation Patella has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2024-11-25Clinical Trial Update: Rheum@Home: RA Remote Patient Monitoring [NA]
A clinical trial for rheumatoid arthritis remote patient monitoring called Rheum@Home was withdrawn.
-
CLINICAL_TRIALS withdrawal · 2023-08-07Clinical Trial Update: MabionCD20® Compared to MabThera® and Rituxan® in Patients With Rheumatoid Arthritis [Phase 3]
Phase 3 trial comparing MabionCD20 to MabThera/Rituxan in rheumatoid arthritis was withdrawn.
-
CLINICAL_TRIALS withdrawal · 2022-05-09Clinical Trial Update: A Multicenter Study to Compare the Efficacy and Safety of the Combination of Etanercept and Methotrexate in Treatment of Rheumatoid Arthritis [Phase 4]
A multicenter Phase 4 trial evaluating etanercept and methotrexate for rheumatoid arthritis was withdrawn.
-
CLINICAL_TRIALS withdrawal · 2021-06-23Clinical Trial Update: Comparison of the Effect of Etoricoxib and Diclofenac on Early Morning Activity in Rheumatoid Arthritis (RA) [Phase 4]
A Phase 4 trial comparing etoricoxib and diclofenac in rheumatoid arthritis has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2021-02-24Clinical Trial Update: Comparison of Two Etanercept Regimens (REUMATOCEPT® Versus ENBREL®) for Treatment of Rheumatoid Arthritis [Phase 3]
Phase 3 trial comparing two etanercept regimens for rheumatoid arthritis was withdrawn.
-
EMA withdrawal · 2019-03-06EMA Withdrawn: Cyltezo (adalimumab) — Boehringer Ingelheim International GmbH
The EMA withdrew Cyltezo (adalimumab) from Boehringer Ingelheim International GmbH, affecting multiple indications including hidradenitis su…
-
EMA withdrawal · 2019-03-05EMA Withdrawn: Solymbic (adalimumab) — Amgen Europe B.V.
Solymbic (adalimumab) has been withdrawn from the market by Amgen Europe B.V.
-
EMA withdrawal · 2018-07-23EMA Refused: Xeljanz (tofacitinib) — Pfizer Limited
The EMA refused approval for Xeljanz (tofacitinib) by Pfizer Limited in the rheumatoid arthritis therapeutic area.
-
CLINICAL_TRIALS withdrawal · 2018-07-11Clinical Trial Update: Study Evaluating Gerilimzumab´s Safety/Efficacy for Patients MTX or TNFα Antagonist Failed in Rheumatoid Arthritis [Phase 2]
A Phase 2 clinical trial evaluating the safety and efficacy of Gerilimzumab in rheumatoid arthritis patients who failed methotrexate or TNF-…
-
EMA withdrawal · 2017-11-10EMA Application withdrawn: Plivensia (sirukumab) — Janssen-Cilag International NV
The EMA withdrew the application for Plivensia (sirukumab) by Janssen-Cilag International NV for rheumatoid arthritis indications.
-
CLINICAL_TRIALS withdrawal · 2017-08-10Clinical Trial Update: Autologous Adipose Tissue Stromal Vascular Fraction Cells for Rheumatoid Arthritis [Phase 1, Phase 2]
A clinical trial evaluating autologous adipose tissue stromal vascular fraction cells for rheumatoid arthritis has been withdrawn (Phase 1/2…
-
CLINICAL_TRIALS withdrawal · 2017-06-28Clinical Trial Update: A Multi-centre Study to Assess the Long-term Performance of the Pinnacle™ Cup With a Polyethylene-on-metal Bearing in Primary Total Hip Replacement [Phase 4]
Phase 4 multi-centre study assessing the long-term performance of the Pinnacle hip cup with a polyethylene-on-metal bearing in primary total…
-
CLINICAL_TRIALS withdrawal · 2017-06-21Clinical Trial Update: A Clinical Investigation of the Comprehensive®, BioModular®, and Bi-Angular® Shoulder Systems
A clinical trial update indicates the investigation of the Comprehensive®, BioModular®, and Bi-Angular® Shoulder Systems sponsored by Biomet…
-
CLINICAL_TRIALS withdrawal · 2017-06-21Clinical Trial Update: A Clinical Investigation of Recovery Following Hip Resurfacing or Total Hip Arthroplasty [NA]
A clinical trial evaluating recovery after hip resurfacing or total hip arthroplasty has been withdrawn.